- Zio Patch Cardiac Monitoring Systems
- Zio Patch Results
- Zio Patch Cardiac Monitoring Center
- Zio Heart Monitor Faq
I recently cared for a 35-year-old woman who presented to the emergency department for evaluation of palpitations. The symptoms lasted for 10 minutes and produced a mild sense of lightheadedness, but there was no chest pain, dyspnea, diaphoresis, syncope, or other typical cardiopulmonary symptoms. The patient reported that she had palpitations a few times in the prior month, and she had presented to another ED after the first episode. At that time, she had an electrocardiogram that was normal, and she had no further workup. She had no other medical problems, took no medications, and had no primary care physician. I was unable to identify any precipitants for the palpitations: no recent changes in diet, medications, illicit drug use, or stress and no use of tobacco, stimulants, or alcohol. Her physical exam, ECG, and electrolytes were completely normal. The patient I described is not unusual to anyone working in the ED. We often see patients like this and debate the management. Given the absence of significant cardiopulmonary complaints, it would be difficult to justify admission, and even a 24-hour ED observation for cardiac monitoring is likely to be low-yield given the infrequency of her symptoms. My normal approach to this patient would be to recommend that she see her primary care physician or a cardiologist within a day for placement of a Holter monitor or event monitor, but given her lack of a primary care physician and the difficulty of obtaining a rapid appointment within our crowded system, I knew that I was not going to be able to help this patient find a quick diagnosis and treatment.
- Enter the Zio Patch, a new wireless (and fully recyclable) device that adheres to the chest for up to 14 days of continuous monitoring, and can simply be removed and mailed in for results.
- The Zio patch cardiac monitor continuously records heart rhythm data for up to 14 days. Unlike traditional Holter monitoring that can leave critical gaps in data, the Zio patch captures uninterrupted data with a median 99% analyzable time.
You Might Also Like
Wearable Patch Holter Monitoring Traditional 24 hour Holter monitoring has evolved substantially in recent years due to the advent of a wearable 3-14 day long term continuous monitoring or long term Holter monitoring patch. Much of the clinical evidence has concluded that there is substantial clinical value in detecting abnormal cardiac arrhythmias with 3-14 times. EPatch is a lightweight cardiac monitor that adheres to the patient’s chest. And unlike other patches, if ePatch loses adhesion it may be replaced by a fresh patch (or small electrode adaptor for sensitive skin) without terminating the recording session. Wearable Patch Holter Monitoring Traditional 24 hour Holter monitoring has evolved substantially in recent years due to the advent of a wearable 3-14 day long term continuous monitoring or long term Holter monitoring patch. Much of the clinical evidence has concluded that there is substantial clinical value in detecting abnormal cardiac arrhythmias with 3-14 times.
- Pediatric In-Hospital Cardiac Arrest: Lower Survival During Nights, Weekends
- Loperamide Abuse Associated with Cardiac Dysrhythmia and Death
- Risk of Sudden Cardiac Arrest from Lyme Carditis Underscores Need for Timely Diagnosis, Treatment
Explore This Issue
ACEP Now: Vol 33 – No 06 – June 2014A Possible Solution?
Zio Patch Cardiac Monitoring Systems
A solution for scenarios like this may be on the way. The ZIO XT Patch is a single-channel continuous-recording ECG monitor, available by prescription, that can be worn up to 14 days by patients being evaluated for possible cardiac dysrhythmias. As stated in the product manual, “it is indicated for use on patients who may be asymptomatic or who may suffer from transient symptoms such as palpitations, shortness of breach, dizziness, lightheadedness, presyncope, syncope, fatigue, or anxiety.” There are no contraindications to its use.
https://where-is-send-or-outbox-in-outlook-2011-for-mac5.peatix.com. A major question comes to mind as I consider the future use of this device: given the potential for widespread availability of the device, will the ZIO XT Patch become yet another overused test in very low- or no-risk populations?
The ZIO XT Patch is applied against the left chest using a simple adhesive and fits under normal clothing (the device is approximately 5 inches x 2 inches with a central button that is one-half-inch raised, and it weighs 24.5 grams). It can be worn all day and night and is waterproof, although water exposure should be minimized whenever possible. The device continuously monitors the heart rhythm, but if the patient feels symptoms, a central button can be pressed to mark the recording. At the end of the 14 days, the patient removes the device and mails it in a prepackaged box to a testing facility in Illinois or California, where the rhythm is analyzed and interpreted. Initial cost estimates are less than $200.
Zio Patch Results
Research Results
Early studies on this device have been very optimistic (although readers must always consider the usual publication bias toward positive studies with new devices). A notable recent study in the Western Journal of Emergency Medicine evaluated 174 patients who had presented to the ED with symptoms of possible cardiac dysrhythmias, most commonly palpitations.1 At the time of discharge, the ZIO XT Patch was applied and worn for up to 14 days or until the patient had symptoms to trigger an event. The overall diagnostic yield for detection of a dysrhythmia was 63 percent. Reverse gamertag lookup youtube. Almost half the patients (48 percent) were noted to have at least one significant dysrhythmia event, defined as ventricular tachycardia, paroxysmal atrial fibrillation, supraventricular tachycardia, >3 second pause, Mobitz II, third-degree AV block, or symptomatic bradycardia. Of note, only 10 percent of patients with significant dysrhythmias were symptomatic at the time of their dysrhythmia, suggesting that traditional event recorders, which rely on patients’ recognition of symptoms, would have failed to detect these episodes. Equally important was the finding that 53 percent of symptomatic patients did not have any dysrhythmias during their triggered events, indicating a non-dysrhythmic cause of symptoms. The median time to first detection of dysrhythmia was one day (interquartile range 0.2–2.8 days), and the median time to first symptomatic event was 1.5 days (interquartile range 0.4–6.7 days), suggesting that traditional 48-hour Holter monitors would have detected a majority, but not all, of the dysrhythmias. The ZIO XT Patch offers a promising alternative to Holter or event monitors for the outpatient evaluation of patients with possible dysrhythmias. However, a major question comes to mind as I consider the future use of this device: given the potential for widespread availability of the device, will the ZIO XT Patch become yet another overused test in very low- or no-risk populations? If this occurs, we’ll undoubtedly encounter an explosion of false-positive results, which could lead to further unnecessary testing and procedures. We’ve already seen this occur with other diagnostic tests, including the D-dimer, cardiac stress tests, the highly sensitive troponins, and coronary CT angiograms. I look forward to reading further studies on this device and hearing the debates that will certainly follow.
Irregular heartbeats can be common, but they can also signal underlying cardiac conditions that may require special monitoring. Patients who do not require hospitalization while being monitored can opt for wearable devices such as the Zio Patch.
Understanding How the Zio Patch Works
Attached to the skin with a medical-grade adhesive, the wireless 2-by-5-inch Zio Patch constantly monitors the heart’s rhythm and keeps the data stored for analysis later on. Because this water-resistant device can be worn all day and night long over the course of several days or weeks, the data it provides is a valuable tool in diagnosing cardiac conditions accurately.
Other wearable cardiac monitors tend to require several nodes and wires, which can be uncomfortable and may produce inaccurate results due to disruption in the signals sent from the nodes to the monitoring device. The technology behind the Zio Patch is able to filter between what it detects as the heart’s rhythm and what may be interference.
When compared to other wearable cardiac monitors, the Zio Patch is favored for its ease of use for patients and its accuracy for diagnosing cardiac events for physicians.
Zio Patch Cardiac Monitoring Center
Side Effects and Risks Associated with the Zio Patch
The Zio Patch has relatively few issues where it concerns adverse reactions or risks to a patient’s health. Patients who may have an allergic reaction to certain adhesive chemicals may not be able to wear a Zio Patch. If the application of the patch results in excessive redness or itching, it should be removed immediately.
Zio Heart Monitor Faq
Some medical conditions that impact cardiac rhythm can interfere with the data a Zio Patch collects and therefore those patients may be advised against using the device due to the chance of receiving inaccurate results. Other medical devices, such as defibrillators, MRI machines or those that emit high frequencies may disrupt how the Zio Patch functions. The patch should be removed before using these devices.
Patients should not share patches with others or reuse a patch from someone else. This can expose them to contaminants or contagions.
Medicare Coverage for the Zio Patch Democracy 3 free mac.
Although this device must be prescribed by a physician for use, it is considered an outpatient diagnostic service and should fall under Original Medicare Part B (medical insurance). Spiderman shattered dimensions pc game setup. It’s unlikely that this device would be used during an inpatient hospital stay covered by Medicare benefits through Part A (hospital insurance).
Part B services can require certain out-of-pocket expenses when there is a deductible to be met and copays or coinsurance amounts associated with the service or test you require. Medigap or Medicare Advantage plans may be able to reduce those cost-sharing obligations, but your options for choosing one of those plans may be limited by your location.
Patients who qualify for certain Medicaid programs as a Medicare recipient can also have their cost-sharing obligations reduced, but eligibility is determined by each state. Because Medicare would still be billed for this diagnostic test, any recipient may need their doctor to submit appropriate documents for prior authorization even if their share-of-costs are covered by an additional insurer.
Related articles:
![Monitoring Monitoring](https://www.mobihealthnews.com/sites/default/files/-ZIO-service-ZIO-patch-for-arrhythmia_0.png)
Can't find the answer you're looking for?
Talk to a Licensed
Insurance Agent
Insurance Agent
Andrew Sivatjian
Licensed Insurance Agent since 2006
One of the most common questions we receive is, 'Can you laminate your Medicare card?' It's a great question because…
People who need help getting in and out of their chair daily due to life changes such as aging, arthritis,…
Everything You Need to Know Many things have changed since Medicare Part C was formally introduced by legislation in 1997.…